Rhenman & Partners Asset Management AB

Holdings History for Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI)

Symbol: ITCI
Investment type: Equity / Common Stock, $0.0001 Par Value Per Share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2025		-1.5%	$0	0	-176,000	-100%	$2540.00	Q1 2025
31 Dec 2024	1.5%	-0.25%	$14,699,520	176,000	-29,500	-14%	$83.52	Q4 2024
30 Sep 2024	1.2%	+0.38%	$15,036,435	205,500	+63,500	+45%	$73.17	Q3 2024
30 Jun 2024	0.93%	+0.03%	$9,725,580	142,000	+4,500	+3.3%	$68.49	Q2 2024
31 Mar 2024	0.9%	+0.31%	$9,515,000	137,500	+47,500	+53%	$69.20	Q1 2024
31 Dec 2023	0.64%	-0.04%	$6,445,800	90,000	-5,000	-5.3%	$71.62	Q4 2023
30 Sep 2023	0.53%	0%	$4,948,550	95,000	0		$52.09	Q3 2023
30 Jun 2023	0.63%	-0.07%	$6,015,400	95,000	-10,000	-9.5%	$63.32	Q2 2023
31 Mar 2023	0.65%	-0.12%	$5,885,250	105,000	-20,000	-16%	$56.05	Q1 2023
31 Dec 2022	0.69%	0%	$6,615,000	125,000	0		$52.92	Q4 2022
30 Sep 2022	0.66%	-0.08%	$5,709,000	125,000	-15,000	-11%	$45.67	Q3 2022
30 Jun 2022	0.91%	-0.91%	$7,991,000	140,000	-140,000	-50%	$57.08	Q2 2022
31 Mar 2022	1.7%	-0.66%	$17,133,000	280,000	-110,000	-28%	$61.19	Q1 2022
31 Dec 2021	1.4%	-0.14%	$20,331,000	390,000	-39,728	-9.2%	$52.13	Q4 2021
30 Sep 2021	1.1%	0%	$16,020,000	429,728	0		$37.28	Q3 2021
30 Jun 2021	1.2%	-0.08%	$17,541,000	429,728	-28,050	-6.1%	$40.82	Q2 2021
31 Mar 2021	1.1%	-0.1%	$15,532,000	457,778	-42,222	-8.4%	$33.93	Q1 2021
31 Dec 2020	1.3%	+0.06%	$15,900,000	500,000	+25,000	+5.3%	$31.80	Q4 2020
30 Sep 2020	1.1%	0%	$12,189,000	475,000	0		$25.66	Q3 2020
30 Jun 2020	1.3%	-0.26%	$12,193,000	475,000	-92,534	-16%	$25.67	Q2 2020
31 Mar 2020	1.2%	+0.15%	$8,723,000	567,534	+67,534	+14%	$15.37	Q1 2020
31 Dec 2019	1.9%	-1.3%	$17,155,000	500,000	-350,000	-41%	$34.31	Q4 2019
30 Sep 2019	0.8%	-0.09%	$6,350,000	850,000	-99,833	-11%	$7.47	Q3 2019
30 Jun 2019	1.4%	0%	$12,329,000	949,833	0		$12.98	Q2 2019
31 Mar 2019	1.4%	+0.41%	$11,569,000	949,833	+289,851	+44%	$12.18	Q1 2019
31 Dec 2018	0.86%	+0.01%	$7,517,000	659,982	+5,000	+0.76%	$11.39	Q4 2018
30 Sep 2018	1.4%	-0.09%	$14,213,000	654,982	-41,975	-6%	$21.70	Q3 2018
30 Jun 2018	1.3%	-0.17%	$12,315,000	696,957	-95,773	-12%	$17.67	Q2 2018
31 Mar 2018	2.1%	-0.76%	$16,687,000	792,730	-291,851	-27%	$21.05	Q1 2018
31 Dec 2017	2.1%	-0.19%	$15,705,000	1,084,581	-95,319	-8.1%	$14.48	Q4 2017
30 Sep 2017	2.4%	+0.7%	$18,619,000	1,179,900	+346,746	+42%	$15.78	Q3 2017
30 Jun 2017	1.5%	+0.21%	$10,348,000	833,154	+117,490	+16%	$12.42	Q2 2017
31 Mar 2017	1.8%	+1.1%	$11,630,000	715,664	+425,664	+147%	$16.25	Q1 2017
31 Dec 2016	0.84%	+0.45%	$4,376,000	290,000	+155,000	+115%	$15.09	Q4 2016
30 Sep 2016	0.34%	+0.05%	$2,057,400	135,000	+20,000	+17%	$15.24	Q3 2016
30 Jun 2016	0.79%	0%	$4,464,000	115,000	0		$38.82	Q2 2016
31 Mar 2016	0.63%	-0.06%	$3,197,000	115,000	-11,000	-8.7%	$27.80	Q1 2016
31 Dec 2015	1%	-0.32%	$6,778,000	126,000	-39,000	-24%	$53.79	Q4 2015
30 Sep 2015	1.1%	-0.26%	$6,607,000	165,000	-41,000	-20%	$40.04	Q3 2015
30 Jun 2015	0.93%	+0.1%	$6,582,000	206,000	+23,000	+13%	$31.95	Q2 2015
31 Mar 2015	0.78%	+0.1%	$4,370,000	183,000	+23,146	+14%	$23.88	Q1 2015
31 Dec 2014	0.84%	+0.06%	$2,821,000	159,854	+10,854	+7.3%	$17.65	Q4 2014
30 Sep 2014	0.63%	+0.21%	$2,043,000	149,000	+50,731	+52%	$13.71	Q3 2014
30 Jun 2014	0.49%	0%	$1,657,000	98,269	0		$16.86	Q2 2014
31 Mar 2014	0.6%	+0.6%	$1,787,000	98,269	+98,269	NEW	$18.18	Q1 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.